BioWorld MedTech

Oct. 21, 2014

MedTech Forum: Halftime over, EU restarts its contentious CE regulation talks

BRUSSELS, Belgium — For those concerned about the revision of rules governing the popular CE mark for commercializing medical devices in Europe, let's say we are somewhere in the third quarter. Read More

MedTech Forum: CE Mark revision: 'We do not want device scrutiny by lottery'

Veracyte developing new test to remove ambiguity from ILD screening

Inside the Beltway: AHRQ survey; multiple chronic conditions still driving spending

Financings: PureTech closes $55 million growth stage investment round

Hit Bits: Toledo Clinic & Outpatient Center selects eClinicalWorks EHR solution

Agreements/contracts: Mediso launches new MRI with new Tesla strength

People in Places

World in Review: MedVenture reports expansion of its operations into Costa Rica

Product briefs

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 11, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026